Navigation Links
Inflammatory Substance May Boost Eye Trouble
Date:10/8/2007

C-reactive protein raises odds of age-related macular degeneration, experts say

MONDAY, Oct. 8 (HealthDay News) -- People with high blood levels of C-reactive protein, a substance associated with inflammation, may be at higher risk of developing age-related macular degeneration (AMD), a major cause of vision loss in older adults.

Dutch researchers collected blood samples and took photographs of the eyes of more than 4,900 people at risk for AMD. They then followed the group for an average of 7.7 years.

During that time, 658 of the participants were diagnosed with AMD -- 561 with initial stage AMD and 97 with advanced AMD.

As an individual's C-reactive protein level increased above the midpoint of the study group, the person became more and more likely to develop AMD, the researchers found.

The study is published in the October issue of the journal Archives of Ophthalmology.

The findings suggest that lowering C-reactive protein levels may help decrease AMD risk, the study authors said.

"A substance that can selectively inhibit C-reactive protein synthesis has not yet been developed, to our knowledge," wrote a team from Erasmus Medical Center, Rotterdam. "Smoking and high body mass index increase C-reactive protein levels. Moderate alcohol intake, diets with a low glycemic index and statin [drugs] and multivitamin use reduce C-reactive protein levels."

It's known that smoking and obesity increase the risk of AMD, which occurs when the macula -- the area at the back of the retina involved in sharp vision -- deteriorates over time.

More information

The U.S. National Eye Institute has more about AMD.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Oct. 8, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Inflammatory bowel disease linked to genetic abnormality
2. Safeguarding anti-inflammatory users from ulcers
3. Gel pares inflammatory activity throughout body
4. The Usage Of Anti-Inflammatory Drugs Questioned
5. Hope For Patients With Inflammatory Bowel Disease
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. Anti-inflammatory drugs reduce the risk of oral cancer for smokers
8. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
9. Cannabinoids drug for inflammatory bowel
10. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
11. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... ... 26, 2016 , ... Intalere, the healthcare industry leader in ... inaugural Member Conference at the Paris Hotel in Las Vegas, Nev., May 17-20, ... America’s healthcare providers. , The conference was highlighted by the announcement of the ...
(Date:5/26/2016)... ... 26, 2016 , ... The Woodlands at John Knox Village , Florida’s ... care for living and healing, celebrated its grand opening, today. The Woodlands at John ... provided by Empowered Staff. , “This is an incredibly fulfilling time for John Knox ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... development solutions for drugs, biologics, consumer health and global clinical supply services, today ... Korea to support the company’s continued investment and strategic growth plans in the ...
(Date:5/26/2016)... ... May 26, 2016 , ... Memorial Day Weekend marks the unofficial ... is sharing tips to make sure your family and vehicle are ready to ... Council, there may be 439 deaths and an additional 50,500 serious injuries from motor ...
(Date:5/26/2016)... ... 26, 2016 , ... North Cypress Medical Center hosted its 9th ... Cypress. With the help of community partners, the event organizers raised $45,000 for the ... wounded service members and their families through health, wellness, and therapeutic support. , ...
Breaking Medicine News(10 mins):
(Date:5/25/2016)... , May 25,2016 FDA ... near-infrared Cellvizio platform for urological and surgical applications ... MKEAY) inventor of Cellvizio®, the multidisciplinary confocal laser ... milestone in the US with the 12 th ... Drug Administration (FDA). This new FDA clearance covers ...
(Date:5/25/2016)... , Germany and GERMANTOWN, ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt Prime Standard: ... licensing and co-development agreement with Therawis Diagnostics GmbH to develop ... be to develop and market PITX2 as a marker to ... high-risk breast cancer patients. "We are pleased to ...
(Date:5/25/2016)... -- According to market research "Global Insulin ... Forecast to 2022 - Industry Insights by Type (Insulin ... P&S Market Research, the global insulin delivery device market ... is expected to grow at a CAGR of 6.6% ... is expected to witness the fastest growth at a ...
Breaking Medicine Technology: